Company / Current Assets
Xenon Pharmaceuticals Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$560.6M
FY2025
5-year range
$559.0M / $645.0M
FY2021-FY2025
Trend
-11.7%
vs FY2024
Sector context
#105 of 213
Health Care
What the data says
At $561M, Xenon Pharmaceuticals Inc.'s current assets ranks #105 of 213 in the Health Care sector. Declined from $645M to $561M over the past 2 years.
Based on SEC 10-K filings.
$561M in FY2025 with a 5-year CAGR of +25.3%.
Declined from $645M to $561M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -2.3%
- 5-Year CAGR
- +25.3%
- 10-Year CAGR
- -
Sector benchmark
#105 of 213 in Health CareTop 49% of 213This company $560.6M Sector average $2.5B
▼
-77.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +25.3%, indicating consistent growth.
- In FY2025, current assets decreased 11.7% year-over-year.
- Ranks #105 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $560.6M | -11.7% |
| FY2024 | $635.3M | -1.5% |
| FY2023 | $645.0M | +7.4% |
| FY2022 | $600.3M | +7.4% |
| FY2021 | $559.0M | +207.5% |
| FY2020 | $181.8M | +25.5% |
| FY2019 | $144.9M | +19.4% |
| FY2018 | $121.3M | +170.7% |
| FY2017 | $44.8M | -31.8% |
| FY2016 | $65.7M | +7.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026